Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24694 | 22589191 | Proteomics | Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet. | 2012 | Details |
| A24696 | 22588928 | Nan Fang Yi Ke Da Xue Xue Bao | [Efficacy of antioxidants in treatment of nonalcoholic fatty liver: a systematic review]. | 2012 | Details |
| A24699 | 22584317 | Gan To Kagaku Ryoho | [Hepatocarcinogenesis in NASH]. | 2012 | Details |
| A24700 | 22583925 | Hepatol Res | Efficacy of rosuvastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study. | 2012 | Details |
| A24704 | 22579612 | Mol Cell Endocrinol | The role of angiotensin II in nonalcoholic steatohepatitis. | 2012 | Details |
| A24705 | 22577564 | Int J Hepatol | Role of NKT Cells in the Pathogenesis of NAFLD. | 2012 | Details |
| A24707 | 22576780 | Diabetes Metab Res Rev | Diabetic fatty liver disease is associated with specific changes in blood-borne markers. | 2012 | Details |
| A24709 | 22576023 | J Gastroenterol | Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? | 2012 | Details |
| A24712 | 22570745 | Gut Liver | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. | 2012 | Details |
| A24716 | 22569299 | Life Sci | The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model. | 2012 | Details |
| A24717 | 22567408 | Int J Hepatol | Mechanisms and biomarkers of apoptosis in liver disease and fibrosis. | 2012 | Details |
| A24720 | 22564417 | J Diabetes | Non-alcoholic fatty liver disease. | 2012 | Details |
| A24728 | 22554494 | Brain Behav Immun | Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. | 2012 | Details |
| A24729 | 22554256 | Aliment Pharmacol Ther | Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. | 2012 | Details |
| A24740 | 22546234 | Eur J Pharmacol | Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes. | 2012 | Details |
| A24741 | 22545719 | Clin Sci (Lond) | Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. | 2012 | Details |
| A24744 | 22544329 | Cell Cycle | The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. | 2012 | Details |
| A24751 | 22537612 | Gastroenterology | Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. | 2012 | Details |
| A24757 | 22532269 | Hepatology | Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. | 2012 | Details |
| A24763 | 22525505 | Zhonghua Gan Zang Bing Za Zhi | [Adiponectin inhibits the activation of hepatic stellate cells induced by TGFb1 via up-regulating the expression of eNOS]. | 2011 | Details |
| A24766 | 22521558 | Clin Res Hepatol Gastroenterol | Non-alcoholic fatty liver disease in children. | 2012 | Details |
| A24767 | 22521357 | J Hepatol | Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24768 | 22521354 | J Hepatol | A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. | 2012 | Details |
| A24769 | 22521350 | J Hepatol | Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24770 | 22520641 | Liver Int | Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. | 2012 | Details |
| A24771 | 22519948 | Scand J Gastroenterol | A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. | 2012 | Details |
| A24774 | 22509248 | PLoS One | Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. | 2012 | Details |
| A24775 | 22509085 | World J Gastroenterol | Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24777 | 22508243 | Hepatology | Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. | 2013 | Details |
| A24780 | 22505276 | Hepatology | Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. | 2012 | Details |
| A24781 | 22505194 | Hepatology | Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. | 2012 | Details |
| A24782 | 22505182 | Int J Mol Med | Markers of activated inflammatory cells correlate with severity of liver damage in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24792 | 22488593 | Hepatology | Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. | 2012 | Details |
| A24805 | 22470565 | PLoS One | Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells. | 2012 | Details |
| A24806 | 22469867 | Int J Mol Med | Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice. | 2012 | Details |
| A24807 | 22469726 | Hepatogastroenterology | The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases. | 2012 | Details |
| A24814 | 22468051 | Indian J Clin Biochem | Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease. | 2011 | Details |
| A24818 | 22467277 | Hepatology | Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. | 2012 | Details |
| A24819 | 22467259 | Hepatology | Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. | 2012 | Details |
| A24830 | 22455888 | Zhonghua Bing Li Xue Za Zhi | [Mechanism of hepatocyte apoptosis in rats with liver fibrosis induced by lipogenic methionine-choline-deficient diet]. | 2012 | Details |
| A24835 | 22446927 | Clin Gastroenterol Hepatol | Features, diagnosis, and treatment of nonalcoholic fatty liver disease. | 2012 | Details |
| A24839 | 22439844 | Clin Sci (Lond) | Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats. | 2012 | Details |
| A24844 | 22435761 | Liver Int | Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. | 2012 | Details |
| A24846 | 22434757 | Pediatr Obes | Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease. | 2012 | Details |
| A24851 | 22432836 | J Gastroenterol Hepatol | Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques. | 2012 | Details |
| A24853 | 22431959 | PLoS One | Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. | 2012 | Details |
| A24857 | 22427237 | Gut | NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. | 2012 | Details |
| A24865 | 22419057 | Dig Dis Sci | Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. | 2012 | Details |
| A24874 | 22418883 | Semin Liver Dis | Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. | 2012 | Details |
| A24885 | 22395188 | J Pediatr Gastroenterol Nutr | Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. | 2012 | Details |
| A24893 | 22385985 | Atherosclerosis | Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. | 2012 | Details |
| A24902 | 22378061 | Hepatology | Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. | 2012 | Details |
| A24905 | 22374723 | Histol Histopathol | Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. | 2012 | Details |
| A24907 | 22373863 | Dig Dis Sci | The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease. | 2012 | Details |
| A24911 | 22371632 | World J Gastroenterol | Role of cytokines and chemokines in non-alcoholic fatty liver disease. | 2012 | Details |
| A24919 | 22360487 | Curr Med Chem | Non-alcoholic steatohepatitis: what can we learn from animal models? | 2012 | Details |
| A24922 | 22359625 | PLoS One | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. | 2012 | Details |
| A24930 | 22345333 | Ann Hepatol | Transient elastography in non-alcoholic fatty liver disease. | 2012 | Details |
| A24932 | 22343513 | Clin Gastroenterol Hepatol | Association between puberty and features of nonalcoholic fatty liver disease. | 2012 | Details |
| A24933 | 22343419 | Free Radic Biol Med | Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. | 2012 | Details |
| A24935 | 22341049 | Ultrasound Med Biol | Liver elasticity in NASH patients evaluated with real-time elastography (RTE). | 2012 | Details |
| A24939 | 22338037 | Am J Clin Nutr | Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24940 | 22334337 | Hepatology | Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. | 2012 | Details |
| A24941 | 22333691 | Hum Immunol | High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation. | 2012 | Details |
| A24944 | 22320918 | J Gastroenterol Hepatol | Pathophysiology guided treatment of nonalcoholic steatohepatitis. | 2012 | Details |
| A24947 | 22328022 | J Gastroenterol | Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. | 2012 | Details |
| A24950 | 22326465 | J Hepatol | Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. | 2012 | Details |
| A24955 | 22314430 | J Hepatol | IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24960 | 22310735 | J Gastroenterol | Inflammation and fibrogenesis in steatohepatitis. | 2012 | Details |
| A24970 | 22295101 | PLoS One | LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. | 2012 | Details |
| A24979 | 22285877 | Magn Reson Imaging | Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. | 2012 | Details |
| A24984 | 22278337 | Diabetologia | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. | 2012 | Details |
| A24995 | 22268100 | Am J Physiol Gastrointest Liver Physiol | Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. | 2012 | Details |
| A24996 | 22268099 | Am J Physiol Gastrointest Liver Physiol | Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. | 2012 | Details |
| A25000 | 22258181 | Hum Genet | A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. | 2012 | Details |
| A25004 | 22253482 | Gut | Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. | 2012 | Details |
| A25007 | 22249728 | Nat Rev Gastroenterol Hepatol | Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. | 2012 | Details |
| A25011 | 22237875 | JPEN J Parenter Enteral Nutr | Nonalcoholic fatty liver disease in pediatric patients. | 2012 | Details |
| A25015 | 22246329 | Eur J Gastroenterol Hepatol | The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population. | 2012 | Details |
| A25030 | 22229957 | Int J Food Sci Nutr | Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A25041 | 22221544 | BMC Gastroenterol | Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. | 2012 | Details |
| A25044 | 22221215 | Nutr Rev | Therapeutic potential of green tea in nonalcoholic fatty liver disease. | 2012 | Details |
| A25047 | 22215946 | World J Gastroenterol | IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice. | 2011 | Details |
| A25051 | 22213086 | Hepatology | Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. | 2012 | Details |
| A25063 | 24331173 | Obes Res Clin Pract | Hepatic tumor necrosis factor-α, leptin and adiponectin expression in morbid obese patients: Clinicopathological correlations. | 2013 | Details |
| A25076 | 22188204 | J Gastroenterol Hepatol | CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation. | 2012 | Details |
| A25081 | 22183968 | Hepatology | Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. | 2012 | Details |
| A25086 | 22183689 | Hepatology | Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25087 | 22183113 | Curr Opin Infect Dis | From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. | 2012 | Details |
| A25092 | 22180989 | Bratisl Lek Listy | Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? | 2011 | Details |
| A25099 | 22173167 | J Hepatol | Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. | 2011 | Details |
| A25103 | 22168074 | Eksp Klin Gastroenterol | [Elastography efficiency in the liver fibrosis determination in patients with nonalcoholic fatty liver disease]. | 2011 | Details |
| A25109 | 22166563 | Ann Hepatol | Serum homocysteine levels in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A25112 | 22161114 | Obes Surg | Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. | 2012 | Details |
| A25113 | 22160635 | Dig Dis Sci | Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. | 2011 | Details |
| A25114 | 22157924 | J Pediatr Gastroenterol Nutr | LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease. | 2012 | Details |
| A25116 | 22157234 | Eur J Gastroenterol Hepatol | Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology. | 2012 | Details |
| A25117 | 22156706 | QJM | Prevalence and markers of advanced liver disease in type 2 diabetes. | 2011 | Details |
| A25122 | 22154902 | Life Sci | Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. | 2011 | Details |
| A25127 | 22152379 | Zhonghua Gan Zang Bing Za Zhi | [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice]. | 2011 | Details |